|
1）Jaiswal S, Chao MP, Majeti R, et al. Macrophages as mediators of tumor immunosurveillance. Trends Immunol. 2010; 31(6): 212-9
|
|
|
|
2）Matozaki T, Murata Y, Okazawa H, et al. Functions and molecular mechanisms of the CD47-SIRPalpha signalling pathway. Trends Cell Biol. 2009; 19(2): 72-80
|
|
|
|
|
|
3）Takenaka K, Prasolava TK, Wang JC, et al. Polymorphism in Sirpa modulates engraftment of human hematopoietic stem cells. Nat Immunol. 2007; 8(12): 1313-23
|
|
|
|
|
|
4）Jaiswal S, Jamieson CH, Pang WW, et al. CD47 is upregulated on circulating hematopoietic stem cells and leukemia cells to avoid phagocytosis. Cell. 2009; 138(2): 271-85
|
|
|
|
|
|
5）Majeti R, Chao MP, Alizadeh AA, et al. CD47 is an adverse prognostic factor and therapeutic antibody target on human acute myeloid leukemia stem cells. Cell. 2009; 138(2): 286-99
|
|
|
|
|
|
6）Willingham SB, Volkmer JP, Gentles AJ, et al. The CD47-signal regulatory protein alpha (SIRPa) interaction is a therapeutic target for human solid tumors. Proc Natl Acad Sci U S A. 2012; 109(7): 6662-7
|
|
|
|
|
|
7）Chao MP, Weissman IL, Majeti R. The CD47-SIRP alpha pathway in cancer immune evasion and potential therapeutic implications. Curr Opin Immunol. 2012; 24(2): 225-32
|
|
|
|
|
|
8）Chao MP, Alizadeh AA, Tang C, et al. Therapeutic antibody targeting of CD47 eliminates human acute lymphoblastic leukemia. Cancer Res. 2011; 71(4): 1374-84
|
|
|
|
|
|
9）Chao MP, Alizadeh AA, Tang C, et al. Anti-CD47 antibody synergizes with rituximab to promote phagocytosis and eradicate non-Hodgkin lymphoma. Cell. 2010; 142(5): 699-713
|
|
|
|
|
|
10）Majeti R. Monoclonal antibody therapy directed against human acute myeloid leukemia stem cells. Oncogene. 2011; 30(9): 1009-19
|
|
|
|
|
|
11）Tseng D, Volkmer JP, Willingham SB, et al. Anti-CD47 antibody-mediated phagocytosis of cancer by macrophages primes an effective antitumor T-cell response. Proc Natl Acad Sci U S A. 2013; 110(27): 11103-8
|
|
|
|
|
|
12）Brown EJ, Frazier WA. Integrin-associated protein (CD47) and its ligands. Trends Cell Biol. 2001; 11(3): 130-5
|
|
|
|
|
|
13）Adams S, van der Laan LJ, Vernon-Wilson E, et al. Signal-regulatory protein is selectively expressed by myeloid and neuronal cells. J Immunol. 1998; 161(4): 1853-9
|
|
|
|
|
|
14）Barclay AN. Signal regulatory protein alpha (SIRP alpha)/CD47 interaction and function. Curr Opin Immunol. 2009; 21(1): 47-52
|
|
|
|
|
|
15）van den Berg TK, van der Schoot CE. Innate immune ‘selfʼ recognition: a role for CD47-SIRP alpha interactions in hematopoietic stem cell transplantation. Trends Immunol. 2008; 29(5): 203-6
|
|
|
|
|
|
16）Oshima K, Ruhul Amin AR, Suzuki A, et al. SHPS-1, a multifunctional transmembrane glycoprotein. FEBS letters. 2002; 519(1-3): 1-7
|
|
|
|
|
|
17）Tsai RK, Discher DE. Inhibition of “self” engulfment through deactivation of myosin-II at the phagocytic synapse between human cells. J Cell Biol. 2008; 180(5): 989-1003
|
|
|
|
|
|
18）Oldenborg PA, Zheleznyak A, Fang YF, et al. Role of CD47 as a marker of self on red blood cells. Science. 2000; 288(5473): 2051-4
|
|
|
|
|
|
19）Khandelwal S, van Rooijen N, Saxena RK. Reduced expression of CD47 during murine red blood cell (RBC) senescence and its role in RBC clearance from the circulation. Transfusion. 2007; 47(9): 1725-32
|
|
|
|
|
|
20）Blazar BR, Lindberg FP, Ingulli E, et al. CD47 (integrin-associated protein) engagement of dendritic cell and macrophage counterreceptors is required to prevent the clearance of donor lymphohematopoietic cells. J Exp Med. 2001; 194(4): 541-9
|
|
|
|
|
|
21）Gardai SJ, McPhillips KA, Frasch SC, et al. Cell-surface calreticulin initiates clearance of viable or apoptotic cells through trans-activation of LRP on the phagocyte. Cell. 2005; 123(2): 321-34
|
|
|
|
|
|
22）Kuriyama T, Takenaka K, Kohno K, et al. Engulfment of hematopoietic stem cells caused by down-regulation of CD47 is critical in the pathogenesis of hemophagocytic lymphohistiocytosis. Blood. 2012; 120(19): 4058-67
|
|
|
|
|
|
23）Akashi K, Hayashi S, Gondo H, et al. Involvement of interferon-gamma and macrophage colony-stimulating factor in pathogenesis of haemophagocytic lymphohistiocytosis in adults. Br J Haematol. 1994; 87(2): 243-50
|
|
|
|
|
|
24）Filipovich A, McClain K, Grom A. Histiocytic disorders: recent insights into pathophysiology and practical guidelines. Biol Blood Marrow Transplant. 2010; 16(1 Suppl): S82-9
|
|
|
|
|
|
25）Ishii E, Ohga S, Imashuku S, et al. Nationwide survey of hemophagocytic lymphohistiocytosis in Japan. Int J Hematol. 2007; 86(1): 58-65
|
|
|
|
|
26）Janka GE. Familial and acquired hemophagocytic lymphohistiocytosis. Eur J Pediatr. 2007; 166(2): 95-109
|
|
|
|
|
|
27）Jordan MB, Allen CE, Weitzman S, et al. How I treat hemophagocytic lymphohistiocytosis. Blood. 2011; 118(15): 4041-52
|
|
|
|
|
|
28）Bizario JC, Feldmann J, Castro FA, et al. Griscelli syndrome: characterization of a new mutation and rescue of T-cytotoxic activity by retroviral transfer of RAB27A gene. J Clin Immunol. 2004; 24(4): 397-410
|
|
|
|
|
|
29）Feldmann J, Callebaut I, Raposo G, et al. Munc13-4 is essential for cytolytic granules fusion and is mutated in a form of familial hemophagocytic lymphohistiocytosis (FHL3). Cell. 2003; 115(4): 461-73
|
|
|
|
|
|
30）Stepp SE, Dufourcq-Lagelouse R, Le Deist F, et al. Perforin gene defects in familial hemophagocytic lymphohistiocytosis. Science. 1999; 286(5446): 1957-9
|
|
|
|
|
|
31）zur Stadt U, Rohr J, Seifert W, et al. Familial hemophagocytic lymphohistiocytosis type 5 (FHL-5) is caused by mutations in Munc18-2 and impaired binding to syntaxin 11. Am J Hum Genet. 2009; 85(4): 482-92
|
|
|
|
|
|
32）zur Stadt U, Schmidt S, Kasper B, et al. Linkage of familial hemophagocytic lymphohistiocytosis (FHL) type-4 to chromosome 6q24 and identification of mutations in syntaxin 11. Hum Mol Genet. 2005; 14(6): 827-34
|
|
|
|
|
|
33）Maciejewski J, Selleri C, Anderson S, et al. Fas antigen expression on CD34＋ human marrow cells is induced by interferon gamma and tumor necrosis factor alpha and potentiates cytokine-mediated hematopoietic suppression in vitro. Blood. 1995; 85(11): 3183-90
|
|
|
|
|
|
34）Morrison SJ, Spradling AC. Stem cells and niches: mechanisms that promote stem cell maintenance throughout life. Cell. 2008; 132(4): 598-611
|
|
|
|
|
|
35）Nagasawa T, Omatsu Y, Sugiyama T. Control of hematopoietic stem cells by the bone marrow stromal niche: the role of reticular cells. Trends Immunol. 2011; 32(7): 315-20
|
|
|
|
|